Tin tức & Cập nhật

Oncologists underestimate patients’ willingness to attend appointments to avoid treatment interruptions during the COVID-19 pandemic, according to a multidisciplinary cross-sectional survey, which shows unaltered willingness to attend scheduled appointments in most cancer patients.

New drug applications approved by US FDA as of 16-30 April 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A survey evaluating paediatric oncology nurses from KK Women’s and Children’s Hospital reveals that they may not be well-versed in terms of oral health knowledge.

The oral, small molecule Wee1 kinase inhibitor adavosertib exerts antitumour effects in patients with advanced recurrent or persistent uterine serous carcinoma, but this benefit appears to be limited by the drug’s tolerability, as shown in the single-arm, phase IIb ADAGIO study.